|
NAMS NewAmsterdam Pharma Company NV 1936258 |
| Balance Sheet |
|
Current Assets
|
$659,207,000.00 |
|
Assets
|
$471,098,000.00 |
|
Current Liabilities
|
$72,974,000.00 |
|
Liabilities
|
$73,030,000.00 |
|
Equity
|
$631,422,000.00 |
|
Shares Out
|
117651697.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-69,818,000.00 |
|
Investing Cash Flow
|
$-16,271,000.00 |
| Market Analysis |
Market Cap
|
$3,268,364,142.66 |
|
Price
|
$22.49 |
|
BVPS
|
5.37 |
|
PB
|
5.17 |
|
EPS
|
-0.52 |
|
PS
|
220.78 |
|
FCF
|
$-69,936,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:17 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAMS documents filed with the SEC.
NAMS Filings
Clear
